Copyright Levies Can Be Imposed On Sale Of Printers, Computers, EU High Court Rules 27/06/2013 by Intellectual Property Watch 2 Comments Governments can impose copyright levies on sales of printers and computers, the European Court of Justice (ECJ) said in a 27 June ruling.
European Commission Fines Pharma Companies For Payments To Delay Generic Entry 19/06/2013 by Brittany Ngo for Intellectual Property Watch 1 Comment The European Commission (EC) has fined Danish pharmaceutical company Lundbeck as well as eight other generic manufacturers for delaying market entry of generic medicines by way of patent settlement agreements (also known as “pay-for-delay” agreements).
US Supreme Court Rules On Pharma Payments To Delay Generic Drugs On Market 17/06/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment The United States Supreme Court in a five to three decision today found that settlement agreements by branded pharmaceutical companies involving payments to generic companies to delay their cheaper drugs’ entry into the market may not be immune from antitrust scrutiny but are not “presumptively” unlawful. The case was sent back to lower court.
US Supreme Court Restricts Gene Patents … A Little 17/06/2013 by Steven Seidenberg for Intellectual Property Watch 2 Comments Last Thursday, the United States Supreme Court overturned more than 30 years of precedents and ruled that isolated genes cannot be patented. They are products of nature and thus not patent-eligible subject matter, the court unanimously held in Assoc. for Molecular Pathology v. Myriad Genetics, Inc. This ruling puts the US at odds with most other nations, which allow genes to be patented. But because other major nations grant narrower gene patents, the net effect of Myriad will be to shift the US position on gene patents closer to that of other nations.
Infojustice: The Topsy-Turvy US International Trade Commission 17/06/2013 by Intellectual Property Watch Leave a Comment Infojustice.org examines the evolving responsibilities of the US International Trade Commission (ITC) and its decision to bar imports of older Apple iPhones and iPads, finding that they infringed patents held by Samsung.
Infojustice: A Bumpy Road To Net Neutrality In Brazil 17/06/2013 by Intellectual Property Watch Leave a Comment Infojustice.org reports: On May 23, Brazil’s federal communications commission – ANATEL – passed a resolution with sweeping implications for internet service provision, net neutrality, and regulatory power.
Myriad Case Decided: Natural Human Genes Not Patentable In US 14/06/2013 by Intellectual Property Watch 3 Comments The United States Supreme Court came to a decision yesterday on the case of Association for Molecular Pathology v. Myriad Genetics, Inc., striking down Myriad’s patent on isolating human genes from the bloodstream.
Poland’s Minister Of Culture Calls For Intellectual Property Courts 14/06/2013 by Jaroslaw Adamowski for Intellectual Property Watch Leave a Comment Poland’s Minister of Culture and National Heritage Bogdan Zdrojewski has called on the country’s Ministry of Justice to create and integrate intellectual property courts into the country’s legal system. Under the plan, the new entities would become departments of regular courts, and they would be solely responsible for handling cases involving intellectual property, including disputes related to authors’ rights, trademarks and patents.
White House Takes Major Action Against “Patent Trolls” 04/06/2013 by William New, Intellectual Property Watch 4 Comments The White House today announced “major steps to improve innovation in high tech patents” by restricting activities of “patent assertion entities,” also known as “patent trolls.” The list included five executive actions and seven legislative recommendations.
US Supreme Court Rules In Favour Of Monsanto In Patent Exhaustion Case 13/05/2013 by Catherine Saez, Intellectual Property Watch 4 Comments The United States Supreme Court found today that a farmer who buys patented seeds may not reproduce them through planting and harvesting without the right holder’s permission. The case, known as Bowman v. Monsanto, revolved around patent exhaustion. The Supreme Court was to decide whether patent exhaustion applied to patented seeds after their authorised sale.